Acute myeloid leukaemia trials in Italy

In Italy 61 Also abroad 763

61 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 14 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients
Where
Bologna
Age
18 years and over
People
22
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06885476
No phaseTaking people
Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade
Where
Bologna
Age
18 years and over
People
20
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06874257
Phase 2Not yet taking people in Italy
Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia
Where
Ancona, Bari, Bergamo, Bologna, Brescia, Castelfranco Veneto, Genoa, Milan, Palermo, Pavia, Perugia, Pescara, Ravenna, Reggio Calabria, Reggio Emilia, Rome, Siena, Turin, ULSS3 SERENISSIMA - Ospedale dell'Angelo di Mestre
Age
18 years to 65 years
People
80
Run by
Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT06667973 · EU 2024-518617-25-00
No phaseTaking people
Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute Leukemia
Where
Perugia
Age
18 years to 65 years
People
51
Run by
University Of Perugia
See details and how to joinNCT06845592
Phase 2Not yet taking people in Italy
Prospective Phase II study on Safety and Efficacy of Fludarabine plus Treosulfan (14g) (FT14) conditioning regimen for allogeneic Stem Cell Transplantation (allo-SCT) in Acute Myeloid Leukemia (AML) patients (≥40 <65years)
Where
Ancona, Ascoli Piceno, Brescia, Catania, Cuneo, Florence, Milan, Modena, Monza, Naples, Reggio Calabria, Roma, Rome, Udine, Venice, Verona
Age
18 years to 64 years
People
82
Run by
Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
See details and how to join2024-520326-11-00
No phaseTaking people
Molecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic Treatments
Where
Bologna
Age
18 years and over
People
20
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06764459
No phaseNot yet taking people in Italy
Epidemiology of Infection in Acute Myeloid Leukemia (AML)
Where
Rome
Age
18 years and over
People
100
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06797648
No phaseTaking people
Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors
Where
Milan
Age
18 years and over
People
157
Run by
European Institute of Oncology
See details and how to joinNCT06785077
Phase 3Taking people
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Where
Alexandria, Ancona, Ascoli Piceno, Avellino, Bari, Barletta, Bologna, Brindisi, Cagliari, Castelfranco Veneto, Civitanova Marche, MC, Cremona, Cuneo, Ferrara, Florence, Foggia, Frosinone, Genoa, Latina, Lecce, Messina, Milan, Milano, Modena, Naples, Novara, Orbassano, Padova, Palermo, Pavia, Perugia, Pesaro, Pescara, Piacenza, Pisa, Ravenna, Reggio Calabria, Reggio Emilia, Rimini, Roma, Rome, Salerno, San Giovanni Rotondo, Sassari, Siena, Statte, Treviso, Tricase, Trieste, Turin, Udine, ASST Valle Olona, Ospedale Valduce, ULSS3 SERENISSIMA - Ospedale dell'Angelo di Mestre
Age
18 years to 60 years
People
414
Run by
Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT04168502 · EU 2023-510433-29-00
Phase 2Taking people
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Where
Ancona, Bergamo, Bologna, Brescia, Cagliari, Catania, Catanzaro, Cosenza, Florence, Genoa, Monza, Naples, Padova, Palermo, Pavia, Pisa, Reggio Calabria, Rimini, Rome, San Giovanni Rotondo, Trieste, Turin, Verona
Age
Up to 18 years
People
89 worldwide
Run by
Associazione Italiana Ematologia Oncologia Pediatrica
See details and how to joinNCT04793919 · EU 2024-518669-83-00
No phaseTaking people
Novel Approaches to Target MECOM/EVI1 in AML
Where
Piacenza
Age
18 years and over
People
24
Run by
Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT05839392